| Catalog Number |
08836973190 |
| Medical Device Problem Code |
False Positive Result (1227)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/05/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
We received an allegation about discrepant results for 2 patients' samples tested with elecsys hiv duo assay on a cobas e 801 analytical unit.Patient 1: the initial result was 1.36 coi.On (b)(6) 2026, the sample was repeated in a different laboratory using 2 different methods (abbott alinity hiv combo and biorad genscreen ultra hiv ag/ab), and the repeat results were both negative.Patient 2: on (b)(6) 2026: the initial result was 2.71 coi.On (b)(6) 2026: the repeat result was 2.48 coi.The sample was also repeated in a different laboratory using 2 different methods (abbott alinity hiv combo and biorad genscreen ultra hiv ag/ab), and the repeat results were both negative.
|
| |
|
Additional Manufacturer Narrative
|
|
The cobas e 801 analytical unit serial number was (b)(6).The provided data showed the calibration on (b)(6) 2026, and it was within the expected ranges.The qc was acceptable.The investigation is ongoing.
|
| |
|
Additional Manufacturer Narrative
|
|
False reactive results may occur in elecsys hiv duo as the specificity of the assay is less than 100% per the labeled specificity claim of the assay.The product labeling states: "all initially reactive samples should be redetermined in duplicate with the elecsys hiv duo assay." the product labeling also states: "repeatedly reactive samples must be confirmed according to cdc recommended confirmatory algorithms." and the product labeling states: "for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.The elecsys hiv duo assay performs within specifications.
|
| |
|
Search Alerts/Recalls
|